Literature DB >> 21982641

Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: report from the Dutch Working Party on Flow Cytometry in MDS.

Theresia M Westers1, Vincent H J van der Velden, Canan Alhan, Roelof Bekkema, André Bijkerk, Rik A Brooimans, Claudia Cali, Angelika M Dräger, Valerie de Haas, Christa Homburg, Anja de Jong, P Ellen A Kuiper-Kramer, Marije Leenders, Ingrid Lommerse, Jeroen G te Marvelde, Joke K van der Molen-Sinke, Bijan Moshaver, Andre B Mulder, Frank W M B Preijers, Roger K Schindhelm, Alita van der Sluijs, Elisabeth R van Wering, August H Westra, Arjan A van de Loosdrecht.   

Abstract

Flow cytometry (FC) is recognized as an important tool in the diagnosis of myelodysplastic syndromes (MDS) especially when standard criteria fail. A working group within the Dutch Society of Cytometry aimed to implement FC in the diagnostic work-up of MDS. Hereto, guidelines for data acquisition, analysis and interpretation were formulated. Based on discussions on analyses of list mode data files and fresh MDS bone marrow samples and recent literature, the guidelines were modified. Over the years (2005-2011), the concordance between the participating centers increased indicating that the proposed guidelines contributed to a more objective, standardized FC analysis, thereby ratifying the implementation of FC in MDS.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21982641     DOI: 10.1016/j.leukres.2011.09.015

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

1.  Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.

Authors:  Kasiani C Myers; Elissa Furutani; Edie Weller; Bradford Siegele; Ashley Galvin; Valerie Arsenault; Blanche P Alter; Farid Boulad; Carlos Bueso-Ramos; Lauri Burroughs; Paul Castillo; James Connelly; Stella M Davies; Courtney D DiNardo; Iftikhar Hanif; Richard H Ho; Nicole Karras; Michelle Manalang; Lisa J McReynolds; Taizo A Nakano; Grzegorz Nalepa; Maxim Norkin; Matthew J Oberley; Etan Orgel; Yves D Pastore; Joseph Rosenthal; Kelly Walkovich; Jordan Larson; Maggie Malsch; M Tarek Elghetany; Mark D Fleming; Akiko Shimamura
Journal:  Lancet Haematol       Date:  2019-12-23       Impact factor: 18.959

Review 2.  Standardizing the initial evaluation for myelodysplastic syndromes.

Authors:  Danielle Marshall; Gail J Roboz
Journal:  Curr Hematol Malig Rep       Date:  2013-12       Impact factor: 3.952

Review 3.  Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?

Authors:  Anna Porwit
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

4.  Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.

Authors:  Theresia M Westers; Eline M P Cremers; Uta Oelschlaegel; Ulrika Johansson; Peter Bettelheim; Sergio Matarraz; Alberto Orfao; Bijan Moshaver; Lisa Eidenschink Brodersen; Michael R Loken; Denise A Wells; Dolores Subirá; Matthew Cullen; Jeroen G Te Marvelde; Vincent H J van der Velden; Frank W M B Preijers; Sung-Chao Chu; Jean Feuillard; Estelle Guérin; Katherina Psarra; Anna Porwit; Leonie Saft; Robin Ireland; Timothy Milne; Marie C Béné; Birgit I Witte; Matteo G Della Porta; Wolfgang Kern; Arjan A van de Loosdrecht
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

5.  Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes.

Authors:  Eline M P Cremers; Theresia M Westers; Canan Alhan; Claudia Cali; Heleen A Visser-Wisselaar; Dana A Chitu; Vincent H J van der Velden; Jeroen G Te Marvelde; Saskia K Klein; Petra Muus; Edo Vellenga; Georgina E de Greef; Marie-Cecile C J C Legdeur; Pierre W Wijermans; Marian J P L Stevens-Kroef; Pedro da Silva-Coelho; Joop H Jansen; Gert J Ossenkoppele; Arjan A van de Loosdrecht
Journal:  Haematologica       Date:  2016-09-22       Impact factor: 9.941

6.  Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.

Authors:  A Porwit; A A van de Loosdrecht; P Bettelheim; L Eidenschink Brodersen; K Burbury; E Cremers; M G Della Porta; R Ireland; U Johansson; S Matarraz; K Ogata; A Orfao; F Preijers; K Psarra; D Subirá; P Valent; V H J van der Velden; D Wells; T M Westers; W Kern; M C Béné
Journal:  Leukemia       Date:  2014-06-12       Impact factor: 11.528

Review 7.  Myelodysplastic Syndromes: Laboratory Workup in the Context of New Concepts and Classification Criteria.

Authors:  Maria Sanz-De Pedro; Wei Wang; Rashmi Kanagal-Shamanna; Joseph D Khoury
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

8.  Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors.

Authors:  Suiellen C Reis-Alves; Fabiola Traina; Konradin Metze; Irene Lorand-Metze
Journal:  Diagn Pathol       Date:  2015-04-29       Impact factor: 2.644

9.  Implementation of the Ogata flow cytometric scoring system in routine diagnostics of myelodysplastic syndrome.

Authors:  Sara Maj Hyldig Matzen; Klas Kræsten Raaschou-Jensen; Klaus Kallenbach
Journal:  Health Sci Rep       Date:  2018-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.